CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

Original ResearchVolume 7, Issue 6, June 2019

JOURNAL:JACC: Heart Failure Article Link

Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

C Balmforth, J Simpson, L Shen et al. Keywords: angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; etiology; heart failure; natriuretic peptide; sneprilysin; treatment

FULL TEXT PDF